<amendment session="107" chamber="h" number="163" updated="2013-07-17T08:15:54-04:00">
  <amends type="h" number="2330" sequence="31"/>
  <status datetime="2001-07-11T17:27:00-04:00">pass</status>
  <sponsor id="400050"/>
  <offered datetime="2001-07-11"/>
  <description>Amendment reallocates FDA funding of $1 million to the Office of Generic Drugs to evaluate and review potential patent abuse.</description>
  <purpose>An amendment to increase the funding by $1,000,000 for responsibilities of the FDA with respect to abbreviated applications for the approval of new drugs.</purpose>
  <actions>
    <action datetime="2001-07-11T17:07:00-04:00">
      <text>Amendment (A031) offered by Mr. Brown (OH).</text>
      <reference ref="CR H3918-3921" label="consideration"/>
      <reference ref="CR H3918-3919" label="text"/>
    </action>
    <vote datetime="2001-07-11T17:27:00-04:00" how="by voice vote" result="pass">
      <text>On agreeing to the Brown (OH) amendment (A031) Agreed to by voice vote.</text>
    </vote>
  </actions>
</amendment>
